ZHONGZHIPHARM released its interim results, with profit attributable to shareholders of 8.783 million yuan, a year-on-year decrease of 89.5%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, ZHONGZHIPHARM released its performance report for the six months ending June 30, 2025, with revenue of 880 million yuan (RMB, the same below), a year-on-year decrease of 19.1%; profit attributable to the parent company owners was 8.783 million yuan, a year-on-year decrease of 89.5%; basic earnings per share were 0.010 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments